Scientists hunt for hidden signs of ALS and FTD in skin and tears

NCT ID NCT06856850

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to find biological markers (biosignatures) in people with ALS and FTD to make diagnosis more precise. Researchers will analyze samples like spinal fluid, skin, and tears from 230 participants using advanced techniques. The goal is to create a 'disease fingerprint' that helps doctors diagnose earlier and track how the disease progresses.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to better, earlier diagnosis of ALS and FTD and help track disease progression more accurately.
What could go wrong
This is an early-stage observational study, not a treatment trial. The biomarkers identified may not prove useful in real-world clinical settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALS - AMYOTROPHIC LATERAL SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Azienda Ospedaliero Universitaria di Sassari

    NOT_YET_RECRUITING

    Sassari, 07100, Italy

  • Consorzio Interuniversitario Risonanze Magnetiche Metallo Proteine (CIRMMP)

    NOT_YET_RECRUITING

    Sesto Fiorentino, 50019, Italy

  • Fondazione IRCCS Istituto Neurologico Carlo Besta

    RECRUITING

    Milan, 20133, Italy

  • Università degli Studi di Napoli "Federico II"

    NOT_YET_RECRUITING

    Naples, 80131, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.